[Problem to be Solved] To Provide a method for producing an acid-decomposable polymer having a reduced metal ion content, which suppresses decomposition and deprotection of the acid-decomposable polymer. [Means to Solve the Problem] The method for producing an acid-decomposable polymer according to the present invention comprises the steps of: preparing a polymer solution comprising an acid-decomposable polymer; washing an acidic cation exchanger with an organic solvent until the water content in the organic solvent discharged from the acidic cation exchanger falls to 400 ppm or less; and passing the polymer solution through the washed acidic cation exchanger to reduce the metal ion content of the polymer.

[Problem to be Solved] To Provide a method for producing an acid-decomposable polymer having a reduced metal ion content, which suppresses decomposition and deprotection of the acid-decomposable polymer. [Means to Solve the Problem] The method for producing an acid-decomposable polymer according to the present invention comprises the steps of: preparing a polymer solution comprising an acid-decomposable polymer; washing an acidic cation exchanger with an organic solvent until the water content in the organic solvent discharged from the acidic cation exchanger falls to 400 ppm or less; and passing the polymer solution through the washed acidic cation exchanger to reduce the metal ion content of the polymer.

The present disclosure relates to a composition that includes ##STR00001##
where A includes at least one of a carbon-carbon bond or a bridging group, R includes between 0 and 4 of a first hydrocarbon, and n is between 2 and 3,000. In some embodiments of the present disclosure, the bridging group may include a linear hydrocarbon chain and/or a branched hydrocarbon chain. In some embodiments of the present disclosure, the bridging group may include between 1 and 10 carbon atoms.

The present disclosure relates to a composition that includes ##STR00001##
where A includes at least one of a carbon-carbon bond or a bridging group, R includes between 0 and 4 of a first hydrocarbon, and n is between 2 and 3,000. In some embodiments of the present disclosure, the bridging group may include a linear hydrocarbon chain and/or a branched hydrocarbon chain. In some embodiments of the present disclosure, the bridging group may include between 1 and 10 carbon atoms.

A polymer composition [composition (M)], said composition (M) comprising i) at least one polyglycolic acid polymer [polymer (PGA)] and ii) at least one amorphous polyester [polymer (APES)], said polymer (APES) being present in the composition (M) in an amount of at least 0.10 and of at most 45 wt %, with respect to the combined weight of polymer (PGA) and polymer (APES). Method of making such composition and method of producing a multilayer stretched product from such composition.

A polymer composition [composition (M)], said composition (M) comprising i) at least one polyglycolic acid polymer [polymer (PGA)] and ii) at least one amorphous polyester [polymer (APES)], said polymer (APES) being present in the composition (M) in an amount of at least 0.10 and of at most 45 wt %, with respect to the combined weight of polymer (PGA) and polymer (APES). Method of making such composition and method of producing a multilayer stretched product from such composition.

The present invention provides new classes of phenol compounds, including those derived from tyrosol and analogues, useful as monomers for preparation of biocompatible polymers, and biocompatible polymers prepared from these monomeric phenol compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processability are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations. The invention also provides methods for preparing these monomeric phenol compounds and biocompatible polymers.

The present invention provides new classes of phenol compounds, including those derived from tyrosol and analogues, useful as monomers for preparation of biocompatible polymers, and biocompatible polymers prepared from these monomeric phenol compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processability are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations. The invention also provides methods for preparing these monomeric phenol compounds and biocompatible polymers.

Copolyesters made from the direct esterification of terephthalic acid with diols including ethylene glycol, but which contain low diethylene glycol (DEG) content, and processes for making the copolyesters. The copolyesters are characterized by comprising 1.0 wt % or less of DEG without requiring the use of DEG-suppressing additives. The processes are characterized by features including operating at lower pressures and lower EG:TPA feed mole ratios in the first reaction zone, while simultaneously at higher temperatures than typical operation in order to lower incorporation of DEG into the final polymer.

Copolyesters made from the direct esterification of terephthalic acid with diols including ethylene glycol, but which contain low diethylene glycol (DEG) content, and processes for making the copolyesters. The copolyesters are characterized by comprising 1.0 wt % or less of DEG without requiring the use of DEG-suppressing additives. The processes are characterized by features including operating at lower pressures and lower EG:TPA feed mole ratios in the first reaction zone, while simultaneously at higher temperatures than typical operation in order to lower incorporation of DEG into the final polymer.